Key Points
- General Motors will record an additional $6 billion EV-related charge in Q4 2025 after weaker demand and the loss of tax credits.
- The write-down reflects a strategic pivot toward capital discipline and higher-margin gasoline vehicles.
- EV-related charges are expected to continue in 2026, though at a materially lower level.
General Motors is taking another sharp accounting hit tied to its electric vehicle ambitions, underscoring the growing gap between early EV optimism and today’s more restrained market reality. In a filing released after the market close Thursday, the automaker disclosed it will record an additional $6 billion charge related to its EV business for the fourth quarter of 2025, reflecting weaker-than-expected demand and the expiration of federal EV tax credits at the end of the third quarter. The move highlights how rapidly the economics of electrification are being reassessed across the U.S. auto sector.
A Costly Reassessment of EV Capacity
The latest charge follows an internal review of EV capacity and investment levels that extended through the fourth quarter. According to the filing, roughly $1.8 billion of the charge consists of non-cash impairments, while approximately $4.2 billion reflects cash costs tied to supplier settlements, contract cancellations, and other restructuring-related expenses. The bulk of the impact sits within GM North America, signaling a recalibration of domestic production plans.
Importantly, GM emphasized that the charge will not affect its adjusted EBIT, a metric closely watched by investors. Still, the size of the write-down speaks to how aggressively the company has had to scale back earlier EV assumptions, particularly as price-sensitive consumers pull back and incentives disappear.
From Expansion to Retrenchment
This $6 billion hit comes on top of a $1.6 billion EV-related charge recorded in the third quarter, bringing total EV write-downs in 2025 to $6.6 billion. Over the past year, GM has reduced EV and battery production targets and redirected some facilities toward gasoline-powered SUVs and trucks, segments that continue to deliver stronger margins and steadier demand.
The pivot reflects a broader industry realization that EV adoption curves are proving less linear than once projected. High interest rates, affordability concerns, and uneven charging infrastructure have all weighed on buyer enthusiasm, forcing automakers to prioritize capital discipline over rapid electrification.
Broader Restructuring Pressures
Beyond North America, GM also disclosed a separate $1.1 billion non-EV charge tied to the restructuring of its China joint venture with SAIC General Motors, with about $500 million involving cash outflows. The disclosure highlights how pressures on profitability are not confined to EVs alone but extend to global operations facing slower growth and rising competition.
Looking ahead, GM said it expects additional EV-related charges in 2026, though it believes they will be “significantly less” than those recorded in 2025. Recent changes to U.S. greenhouse gas emissions standards could further affect the company’s ability to generate revenue from emissions credits, adding another layer of uncertainty.
Industry Context and Investor Implications
GM is not alone in pulling back. Rival Ford recently booked a $19.5 billion charge tied largely to weak demand for large electric trucks, reinforcing the sense that the EV market is entering a more selective, margin-focused phase. For investors, these moves suggest that near-term earnings stability may increasingly depend on legacy vehicles, even as long-term electrification goals remain intact.
GM is set to provide more detail when it reports earnings on Jan. 27, a moment that will be closely watched for signals on capital allocation and EV strategy going forward.
Comparison, examination, and analysis between investment houses
Leave your details, and an expert from our team will get back to you as soon as possible
* This article, in whole or in part, does not contain any promise of investment returns, nor does it constitute professional advice to make investments in any particular field.
To read more about the full disclaimer, click here- Lior mor
- •
- 6 Min Read
- •
- ago 3 days
SKN | Merck Eyes Revolution Medicines in Strategic Cancer Drug Expansion
Merck is reportedly in discussions to acquire Revolution Medicines, a clinical-stage biotechnology company focused on targeted cancer therapies, according
- ago 3 days
- •
- 6 Min Read
Merck is reportedly in discussions to acquire Revolution Medicines, a clinical-stage biotechnology company focused on targeted cancer therapies, according
- sagi habasov
- •
- 7 Min Read
- •
- ago 4 days
SKN | Can Eli Lilly Sustain Growth Beyond GLP-1s With Its $1.2 Billion Ventyx Acquisition?
Eli Lilly’s agreement to acquire Ventyx Biosciences for $1.2 billion in cash signals a deliberate strategic pivot as the pharmaceutical
- ago 4 days
- •
- 7 Min Read
Eli Lilly’s agreement to acquire Ventyx Biosciences for $1.2 billion in cash signals a deliberate strategic pivot as the pharmaceutical
- Ronny Mor
- •
- 6 Min Read
- •
- ago 5 days
SKN | Lilly’s Talks With Ventyx Signal Renewed Deal Appetite in Biopharma
Eli Lilly is in discussions to acquire Ventyx Biosciences for more than $1 billion, according to a report by
- ago 5 days
- •
- 6 Min Read
Eli Lilly is in discussions to acquire Ventyx Biosciences for more than $1 billion, according to a report by
- omer bar
- •
- 7 Min Read
- •
- ago 6 days
SKN | Can Jollibee’s Planned US Listing Redefine the Global Fast-Food Competitive Map?
Jollibee Foods Corp., the Philippine fast-food powerhouse long viewed as a regional champion, is taking a decisive step toward global
- ago 6 days
- •
- 7 Min Read
Jollibee Foods Corp., the Philippine fast-food powerhouse long viewed as a regional champion, is taking a decisive step toward global